Paola Parronchi Selected Research

Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)

1/2019	Sensitization to amoxicillin/clavulanic acid may underlie severe rashes in children treated for infectious mononucleosis.
10/2018	Amoxicillin/clavulanic acid-induced exfoliative dermatitis in a child.
1/2017	T-cell activation in two cases of Stevens-Johnson syndrome after receiving amoxicillin-clavulanic acid.
5/2016	Drug fever after a single dose of amoxicillin-clavulanic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Parronchi Research Topics

Disease

8	Inflammation (Inflammations) 11/2022 - 01/2009
8	Asthma (Bronchial Asthma) 05/2022 - 01/2010
7	COVID-19 10/2022 - 01/2020
5	Hypersensitivity (Allergy) 01/2022 - 04/2011
4	Infections 10/2022 - 01/2021
3	Neoplasms (Cancer) 10/2022 - 04/2002
3	Myositis (Idiopathic Inflammatory Myopathies) 10/2022 - 01/2015
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 10/2016
2	Dermatomyositis (Dermatopolymyositis) 10/2022 - 01/2015
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 09/2020
2	Muscular Diseases (Myopathy) 01/2022 - 10/2020
2	Vasculitis (Vasculitides) 01/2022 - 01/2022
2	Communicable Diseases (Infectious Diseases) 01/2022 - 09/2007
2	Proteinuria 01/2021 - 01/2020
1	Calcinosis 10/2022
1	Inclusion Body Myositis 10/2022
1	Skin Manifestations 10/2022
1	Rhinosinusitis 05/2022
1	Nasal Polyps (Nasal Polyp) 05/2022
1	Atopic Dermatitis (Atopic Eczema) 05/2022
1	Serositis 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Immediate Hypersensitivity 01/2022
1	Urticaria (Hives) 01/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Opportunistic Infections (Opportunistic Infection) 01/2022
1	Enterocolitis 01/2022
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2022
1	Biliary Tract Diseases 01/2022
1	Pulmonary Arterial Hypertension 01/2022
1	Pericarditis 01/2022
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2022
1	Leishmaniasis 01/2022
1	Sudden Infant Death (SID) 09/2021
1	Primary Immunodeficiency Diseases 01/2021
1	autosomal dominant familial Periodic fever 01/2021
1	Cytokine Release Syndrome 12/2020
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 10/2020
1	Disease Progression 09/2020
1	Clinical Deterioration 09/2020
1	Lymphadenopathy 01/2020

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 10/2022 - 01/2015
5	CytokinesIBA 01/2020 - 04/2002
4	Biological ProductsIBA 11/2022 - 01/2018
4	Immunoglobulin E (IgE)IBA 03/2021 - 08/2014
4	AllergensIBA 12/2019 - 02/2003
4	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 01/2019 - 05/2016
4	Adenine FDA LinkGeneric 01/2016 - 01/2009
3	Monoclonal AntibodiesIBA 10/2022 - 12/2020
3	Pharmaceutical PreparationsIBA 10/2022 - 01/2022
3	mepolizumabIBA 02/2022 - 09/2020
3	C-Reactive ProteinIBA 01/2022 - 09/2020
3	SteroidsIBA 01/2022 - 10/2018
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 09/2007
3	tocilizumab (atlizumab)FDA Link 12/2020 - 10/2016
3	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2016 - 04/2002
3	Interleukin-17 (Interleukin 17)IBA 01/2016 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2022
2	AntibodiesIBA 10/2022 - 10/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 09/2020
2	Immunoglobulin M (IgM)IBA 01/2022 - 01/2021
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2022 - 01/2022
2	beta-LactamsIBA 01/2022 - 10/2020
2	Colchicine FDA LinkGeneric 01/2022 - 01/2020
2	InterleukinsIBA 01/2022 - 08/2007
2	VaccinesIBA 09/2021 - 04/2011
2	COVID-19 VaccinesIBA 09/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 09/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 10/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2020
2	Omalizumab (Xolair)FDA Link 08/2020 - 12/2018
2	InterferonsIBA 01/2015 - 08/2007
1	remdesivirIBA 10/2022
1	Ligases (Synthetase)IBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	dupilumabIBA 05/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	TransferasesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Carnitine palmitoyl transferase 2 deficiencyIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	diphenylthiosulfinate (DPTS)IBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	mRNA VaccinesIBA 09/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2021
1	BNT162 VaccineIBA 01/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Oxygen (Dioxygen)IBA 12/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020
1	Toll-Like Receptor 7IBA 01/2020

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2018
2	Critical Care (Surgical Intensive Care) 12/2020 - 01/2020
1	Contraindications 09/2021